BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23853697)

  • 1. Humoral autoimmune response heterogeneity in the spectrum of primary biliary cirrhosis.
    Dellavance A; Cançado EL; Abrantes-Lemos CP; Harriz M; Marvulle V; Andrade LE
    Hepatol Int; 2013 Jun; 7(2):775-84. PubMed ID: 23853697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving liver inflammation in biochemically normal individuals with anti-mitochondria antibodies.
    Baldo DC; Dellavance A; Ferraz MLG; Andrade LEC
    Auto Immun Highlights; 2019 Dec; 10(1):10. PubMed ID: 32257066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of anti-mitochondrial 2-oxoacid dehydrogenase complex subunit's antibodies for the diagnosis of primary biliary cholangitis.
    Poyatos E; Morandeira F; Climent J; Mas V; Castellote J; Bas J
    Clin Immunol; 2021 May; ():108749. PubMed ID: 33945872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis.
    Gabeta S; Norman GL; Liaskos C; Papamichalis PA; Zografos T; Garagounis A; Rigopoulou EI; Dalekos GN
    J Clin Immunol; 2007 Jul; 27(4):378-87. PubMed ID: 17514501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of positive immunoblotting but negative immunofluorescence for antimitochondrial antibodies in patients with liver diseases other than primary biliary cirrhosis.
    Masuda J; Omagar K; Miyakawa H; Hazama H; Ohba K; Kinoshita H; Matsuo I; Isomoto H; Murata I; Kohno S
    Autoimmunity; 2002 Mar; 35(2):135-41. PubMed ID: 12071436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies.
    Moteki S; Leung PS; Coppel RL; Dickson ER; Kaplan MM; Munoz S; Gershwin ME
    Hepatology; 1996 Jul; 24(1):97-103. PubMed ID: 8707289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis.
    Nishio A; Van de Water J; Leung PS; Joplin R; Neuberger JM; Lake J; Björkland A; Tötterman TH; Peters M; Worman HJ; Ansari AA; Coppel RL; Gershwin ME
    Hepatology; 1997 May; 25(5):1085-9. PubMed ID: 9141421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum reactivity against bacterial pyruvate dehydrogenase: increasing the specificity of anti-mitochondrial antibodies for the diagnosis of primary biliary cirrhosis.
    Miyakawa H; Tanaka A; Selmi C; Hosoya N; Mataki N; Kikuchi K; Kato T; Arai J; Goto T; Gershwin ME
    Clin Dev Immunol; 2006; 13(2-4):289-94. PubMed ID: 17162370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis.
    Reynoso-Paz S; Leung PS; Van De Water J; Tanaka A; Munoz S; Bass N; Lindor K; Donald PJ; Coppel RL; Ansari AA; Gershwin ME
    Hepatology; 2000 Jan; 31(1):24-9. PubMed ID: 10613723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis: nuclear immunofluorescence patterns and ELISA reactivities.
    Parveen S; Morshed SA; Nishioka M
    J Gastroenterol Hepatol; 1995; 10(4):438-45. PubMed ID: 8527711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial changes in enzyme inhibitory antibody to pyruvate dehydrogenase complex during the course of primary biliary cirrhosis.
    Hazama H; Omagari K; Masuda J; Kinoshita H; Ohba K; Sakimura K; Matsuo I; Isomoto H; Murase K; Murata I; Kohno S
    J Clin Lab Anal; 2000; 14(5):208-13. PubMed ID: 11018798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue Disease.
    Ceribelli A; Isailovic N; Gorlino C; Assandri R; Vecellio M; De Santis M; Satoh M; Selmi C
    Front Immunol; 2022; 13():822996. PubMed ID: 35296099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum immunological profile in patients with chronic autoimmune cholestasis.
    Romero-Gómez M; Wichmann I; Crespo J; Parés A; Rodrigo L; Alvarez A; Diago M; Pons-Romero F; Sanchez-Munoz D; Aguilar-Reina J; Andrade RJ; Salmeron J; Sánchez-Pobre P; Rebollo JM; Martin-Vivaldi R; Castellano-Megias V; Nuñez-Roldan A; Bruguera M;
    Am J Gastroenterol; 2004 Nov; 99(11):2150-7. PubMed ID: 15554996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between histopathological findings of the liver and IgA class antibodies to 2-oxo-acid dehydrogenase complex in primary biliary cirrhosis.
    Masuda J; Omagari K; Ohba K; Hazama H; Kadokawa Y; Kinoshita H; Hayashida K; Hayashida K; Ishibashi H; Nakanuma Y; Kohno S
    Dig Dis Sci; 2003 May; 48(5):932-8. PubMed ID: 12772793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis.
    Villalta D; Seaman A; Tiongson M; Warren C; Bentow C; Bizzaro N; Alessio MG; Porcelli B; Norman GL; Mahler M
    Clin Chem Lab Med; 2020 Aug; 58(9):1499-1507. PubMed ID: 32286240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a lipoyl domain-independent B-cell autoepitope on the human branched-chain acyltransferase in primary biliary cirrhosis and overlap syndrome with autoimmune hepatitis.
    Csepregi A; Obermayer-Straub P; Kneip S; Kayser A; Loges S; Schmidt E; Nemesánszky E; Szalay F; Manns MP; Strassburg CP
    Clin Dev Immunol; 2003; 10(2-4):173-81. PubMed ID: 14768949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis.
    Tanaka A; Nezu S; Uegaki S; Mikami M; Okuyama S; Kawamura N; Aiso M; Gershwin ME; Takahashi S; Selmi C; Takikawa H
    Ann N Y Acad Sci; 2007 Jun; 1107():259-70. PubMed ID: 17804554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic.
    Bogdanos DP; Baum H; Okamoto M; Montalto P; Sharma UC; Rigopoulou EI; Vlachogiannakos J; Ma Y; Burroughs AK; Vergani D
    Hepatology; 2005 Aug; 42(2):458-65. PubMed ID: 16025495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature.
    Bizzaro N; Covini G; Rosina F; Muratori P; Tonutti E; Villalta D; Pesente F; Alessio MG; Tampoia M; Antico A; Platzgummer S; Porcelli B; Terzuoli L; Liguori M; Bassetti D; Brusca I; Almasio PL; Tarantino G; Bonaguri C; Agostinis P; Bredi E; Tozzoli R; Invernizzi P; Selmi C
    Clin Rev Allergy Immunol; 2012 Jun; 42(3):288-97. PubMed ID: 21188646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis.
    Ikuno N; Mackay IR; Jois J; Omagari K; Rowley MJ
    J Gastroenterol Hepatol; 2001 Dec; 16(12):1390-4. PubMed ID: 11851838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.